{"latest_checked": "2026-07-29T22:11:07.860409+00:00", "coverage_count": 5079, "recent_count": 11, "transaction_limit": 160, "filters": {"q": "", "ticker": "OLMA", "sector": "", "industry": "", "side": "", "start": "2026-06-15", "end": "2026-07-30"}, "summary": {"total": 11, "acquisition_count": 11, "disposal_count": 0, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 0.0, "disposal_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "flow_tone": "positive", "largest_value_label": "$0", "top_sector": "Healthcare", "window_label": "15 Jun 2026 to 30 Jul 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 11, "value": "0.0000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$0"}], "days": [{"transaction_date": "2026-06-18", "acquisitions": 11, "disposals": 0, "total": 11, "bar_width": 100.0}], "side_mix": {"acquisitions": 11, "disposals": 0, "acquisition_share": 100.0, "disposal_share": 0.0}}, "company_flows": [{"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-06-18", "acquisitions": 11, "disposals": 0, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 100.0, "disposal_share": 0.0, "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}], "company_overview": [{"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-06-18", "filings": 11, "acquisitions": 11, "disposals": 0, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}], "transactions": [{"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "BUTITTA, CYNTHIA M", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 29500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:53:05.975365+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}, {"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "BVF, PARTNERS L P/IL", "executive_title": "Director, See Explanation of Responses", "security_type": "Stock Option (Right to buy)", "side_code": "A", "side": "Acquisition", "shares": 29500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:53:05.972009+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}, {"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "CLARK, IAN T", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 29500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:53:05.962505+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}, {"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "GARLAND, J. SCOTT", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 29500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:53:05.966709+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}, {"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "GRAHAM, G. WALMSLEY", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 29500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:53:05.977160+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}, {"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "HARMON, CYRUS", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 29500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:53:05.973534+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}, {"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "HORNING, SANDRA", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 29500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:53:05.959708+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}, {"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "HRUSTANOVIC, GORJAN", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 29500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:53:05.964832+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}, {"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "LARSON, YI", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 29500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:53:05.970305+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}, {"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "RAMAN, PRAKASH", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 29500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:53:05.968507+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}, {"symbol": "OLMA", "name": "Olema Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "RAPPAPORT, ANDREW", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 29500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:53:05.979230+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/olma/", "research_links": {"chart": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/", "report": "/terminal/c22df54b-1fd5-4654-a5de-2e14d3453d20/report/", "factor": "/factors/ticker/c22df54b-1fd5-4654-a5de-2e14d3453d20/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}